AROMANDO ANDREW enters ONCOLYTICS BIOTECH INC with 25.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2026ACC: 0001493152-26-000129
Officer· Chief Business Officer
Since Feb 2026
25.50K
Baseline shares
100% direct
25.50K
Direct ownership
1 position
1.30M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned25.50K
Total
25.50K direct25.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 25.50K | Direct |
| Total | 25.50K | 25.50K direct |
Derivative Holdings3
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
300K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
250K
Shares owned
N/A
Exercise price
0.99
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
750K
Shares owned
N/A
Exercise price
0.93
Expiration
—
Exercise window
—
Total
Underlying
1.30M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Shares | 1.08 | — | — | 300K | N/A |
| Stock Option Direct | Common Shares | 0.99 | — | — | 250K | N/A |
| Stock Option Direct | Common Shares | 0.93 | — | — | 750K | N/A |
| Total | 1.30M | 0.00 | ||||